Department of Biomedical Engineering, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Hypertension. 2010 Nov;56(5):901-6. doi: 10.1161/HYPERTENSIONAHA.110.157370. Epub 2010 Sep 13.
Fat in the renal sinus (RS), a region of the kidney in which low pressure venous and lymphatic vessels are present, may indirectly influence blood pressure. The purpose of this study was to assess the association between RS fat and control of blood pressure on receipt of antihypertensive medications. A total of 205 participants aged 55 to 85 years at risk for cardiovascular events underwent MRI assessments of abdominal and RS fat, measurement of blood pressure, and determination of the number of prescribed antihypertensive medications. Multivariable linear regression was used to determine associations among RS fat, blood pressure, and the number of prescribed antihypertensive medications. Abdominal fat averaged 416±160 cm(3) (median and interquartile range of 396 cm(3) and 308 to 518 cm(3)); intraperitoneal fat averaged 141±73 cm(3) (median and interquartile range of 129 cm(3) and 86 to 194 cm(3)); and RS fat averaged 4.6±3.2 cm(3) (median and interquartile range of 4.2 cm(3) and 2.2 to 6.6 cm(3)). After accounting for age, sex, height, body mass index, and intraperitoneal fat, RS fat correlated with the number of prescribed antihypertensive medications (P=0.010), stage II hypertension (P=0.02), and renal size (P≤0.001). In conclusion, after accounting for other body fat depots and risk factors for hypertension, RS fat volume is associated with the number of prescribed antihypertensive medications and stage II hypertension. These results indicate that further studies are warranted to determine whether fat accumulation in the RS promotes hypertension.
肾窦脂肪(RS)位于肾脏的一个区域,其中存在低压静脉和淋巴管,可能间接影响血压。本研究旨在评估 RS 脂肪与接受抗高血压药物治疗时血压控制之间的关系。共有 205 名年龄在 55 至 85 岁之间、有心血管事件风险的参与者接受了腹部和 RS 脂肪的 MRI 评估、血压测量和处方抗高血压药物数量的测定。多变量线性回归用于确定 RS 脂肪、血压和处方抗高血压药物数量之间的关系。腹部脂肪平均为 416±160cm³(中位数和四分位距为 396cm³和 308 至 518cm³);腹膜内脂肪平均为 141±73cm³(中位数和四分位距为 129cm³和 86 至 194cm³);RS 脂肪平均为 4.6±3.2cm³(中位数和四分位距为 4.2cm³和 2.2 至 6.6cm³)。在考虑了年龄、性别、身高、体重指数和腹膜内脂肪后,RS 脂肪与处方抗高血压药物的数量(P=0.010)、二期高血压(P=0.02)和肾脏大小(P≤0.001)相关。总之,在考虑了其他身体脂肪储存库和高血压的危险因素后,RS 脂肪体积与处方抗高血压药物的数量和二期高血压相关。这些结果表明,需要进一步研究以确定 RS 脂肪堆积是否会促进高血压。